Lim Bryant David
Insider CIK 1752888 · PRLD Chief Legal Officer, Corp Sec. · IDRA SVP and General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PRLD Prelude Therapeutics Inc | A Award deriv | 2026-02-04 | 2026-02-05 | 275,000 | — | $0 | 275,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2025-02-04 | 2025-02-05 | 200,000 | — | $0 | 200,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2024-12-19 | 2024-12-20 | 25,000 | $0.91 | $22.8K | 27,400 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2024-05-14 | 2024-05-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2024-03-01 | 2024-03-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2023-05-24 | 2023-05-25 | 2,400 | $5.39 | $12.9K | 2,400 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2023-03-01 | 2023-03-02 | 250,000 | — | $0 | 250,000 | SEC↗ |
| ACGN Aceragen, Inc. | A Award deriv | 2023-01-20 | 2023-02-02 | 25,400 | — | $0 | 25,400 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | F Tax w/h | 2023-01-06 | 2023-01-10 | 119,957 | $0.71 | $85.2K | 309,695 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award | 2023-01-06 | 2023-01-10 | 399,218 | — | $0 | 429,652 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2022-07-06 | 2022-07-07 | 66,500 | — | $0 | 66,500 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2022-04-01 | 2022-04-04 | 41,500 | — | $0 | 41,500 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2022-01-24 | 2022-01-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2021-07-08 | 2021-07-12 | 66,500 | — | $0 | 66,500 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | S Sale | 2021-03-25 | 2021-03-29 | 7,630 | $1.36 | $10.4K | 30,434 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | S Sale | 2021-01-12 | 2021-01-12 | 1,711 | $4.21 | $7.2K | 38,064 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2021-01-08 | 2021-01-12 | 51,000 | — | $0 | 51,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | S Sale | 2021-01-05 | 2021-01-11 | 1,465 | $3.91 | $5.7K | 39,775 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2020-07-21 | 2020-07-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2020-01-10 | 2020-01-14 | 50,000 | — | $0 | 50,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award | 2020-01-10 | 2020-01-14 | 20,000 | — | $0 | 41,240 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | S Sale | 2020-01-07 | 2020-01-10 | 1,603 | $1.78 | $2.9K | 21,240 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | S Sale | 2020-01-07 | 2020-01-14 | 1,603 | $1.78 | $2.9K | 21,240 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2019-07-09 | 2019-07-11 | 45,500 | — | $0 | 45,500 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2019-01-03 | 2019-01-07 | 45,500 | — | $0 | 45,500 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award | 2019-01-03 | 2019-01-07 | 18,100 | — | $0 | 22,843 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | P Buy | 2018-12-21 | 2018-12-26 | 4,000 | $3.05 | $12.2K | 4,743 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2018-09-10 | 2018-09-13 | 130,000 | — | $0 | 130,000 | SEC↗ |